利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

9 条记录 (耗时 0.024 秒)

    Method of and system for planning a surgery
    2.
    发明申请
    Method of and system for planning a surgery 有权
    手术方法和系统规划

    公开(公告)号：US20090043556A1

    公开(公告)日：2009-02-12

    申请号：US12221858

    申请日：2008-08-06

    申请人： Stuart L. Axelson ,  Jens Rueber ,  Jose Luis Moctezuma de la Barrera ,  Peter Zimmerman

    发明人： Stuart L. Axelson ,  Jens Rueber ,  Jose Luis Moctezuma de la Barrera ,  Peter Zimmerman

    IPC分类号： G06G7/60 ,  G06F9/455

    CPC分类号： A61B19/50 ,  A61B17/1764 ,  A61B34/10 ,  A61B34/25 ,  A61B90/36 ,  A61B2017/0268 ,  A61B2034/101 ,  A61B2034/107 ,  A61B2034/2068 ,  A61B2034/252 ,  A61B2034/254 ,  G06F17/50 ,  G06F19/00 ,  G16H50/50

    摘要： A system for virtually planning a size and position of a prosthetic implant for a bone on a patient includes a database containing pre-defined form factor information for a plurality of different implants and a circuit for obtaining surface shape information of the bone. The system further includes a circuit for defining baseline location parameters for an implant location in relation to a virtual representation of the bone based on the surface shape information and a circuit for assessing a fit calculation of each implant in relation to the virtual representation of the bone based on the form factor in formation and a plurality of fit factors at each of a plurality of incremental positions in relation to the bone. Still further, the system includes a circuit for selecting a best fit implant size and position from all of the fit calculations.

    摘要翻译： 用于虚拟地计划用于患者的骨骼的假体植入物的尺寸和位置的系统包括包含用于多个不同植入物的预定义形状因子信息的数据库和用于获得骨的表面形状信息的电路。 该系统还包括一个电路，用于基于表面形状信息定义相对于骨的虚拟表示的植入位置的基线位置参数，以及用于评估每个植入物相对于骨的虚拟表示的拟合计算的电路 基于形成因子和相对于骨骼的多个增量位置中的每一个处的多个拟合因子。 此外，该系统包括用于从所有拟合计算中选择最佳拟合植入物尺寸和位置的电路​​。

    Device for testing unset concrete and mortar
    5.
    发明授权
    Device for testing unset concrete and mortar 失效
    用于测试混凝土和砂浆的设备

    公开(公告)号：US5541855A

    公开(公告)日：1996-07-30

    申请号：US375006

    申请日：1995-01-18

    申请人： Ruedi Enzler ,  Elfrun Lembke ,  Gunter Lueth ,  Peter Zimmerman ,  Eberhard Schmidt

    发明人： Ruedi Enzler ,  Elfrun Lembke ,  Gunter Lueth ,  Peter Zimmerman ,  Eberhard Schmidt

    IPC分类号： G01N11/14 ,  G01N33/38 ,  B01F15/00

    CPC分类号： G01N33/383 ,  G01N11/14

    摘要： A rotating testing device can be connected to a base unit. A temperature sensor can also be connected to the base unit. The testing device has probe heads. The probe heads are immersed and rotated in the liquid concrete and the force required for rotation is measured in the base unit. Various concrete recipes are stored in a memory of the base unit. Data concerning the concrete are calculated by comparison with the force required to rotate the testing device with the force derived from a respective stored characteristic line and are read from a display field. A concrete recipe and specific measurements are selected by actuating keys which select the respective electronic processes in the base unit for measurement and comparison with stored characteristic data.

    摘要翻译： 旋转测试装置可以连接到基本单元。 温度传感器也可以连接到基座单元。 测试装置有探头。 探针头在液体混凝土中浸没并旋转，在基座单元中测量旋转所需的力。 各种具体配方存储在基本单元的存储器中。 通过与从相应存储的特征线导出的力旋转测试装置所需的力的比较来计算关于混凝土的数据，并从显示领域读取。 通过启动键来选择具体的配方和特定的测量，所述键选择基本单元中的各个电子处理以进行测量并与存储的特征数据进行比较。

    Pharmaceutical products and lactosyl compounds
    8.
    发明授权
    Pharmaceutical products and lactosyl compounds 失效
    药品和乳糖基化合物

    公开(公告)号：US5010059A

    公开(公告)日：1991-04-23

    申请号：US210838

    申请日：1988-06-24

    申请人： Richard R. Schmidt ,  Thomas Baer ,  Peter Zimmerman ,  Albrecht Wendel

    发明人： Richard R. Schmidt ,  Thomas Baer ,  Peter Zimmerman ,  Albrecht Wendel

    IPC分类号： C07H15/04 ,  A61K31/70 ,  A61K31/7028 ,  A61P7/10 ,  A61P9/08 ,  A61P9/10 ,  A61P29/00 ,  C07H15/10

    CPC分类号： C07H15/10 ,  A61K31/70

    摘要： The compounds of the formula I exert a pronounced specific cytoprotective effect; they can be used for the treatment of acute and chronic inflammations and organ ischemias caused by narrowing of vessels. R.sup.1 denotes an aliphatic radical having 9 to 19 C atoms in the straight chain, R.sup.2 denotes the acyl radical of a saturated or unsaturated fatty acid having 14 to 24 C atoms, and X denotes a --CH.sub.2 CH.sub.2 --or --CH.dbd.CH-- group. The invention relates to pharmaceutical products in which the active ingredient is the said compounds, as well as to those compounds I in which R.sup.2 denotes the acyl radical of an unsaturated fatty acid, and to the process for the preparation thereof. ##STR1##

    摘要翻译： 式I的化合物发挥显着的特异性细胞保护作用; 它们可用于治疗由血管狭窄引起的急性和慢性炎症和器官缺血。 R1表示直链中具有9至19个C原子的脂族基团，R2表示具有14至24个C原子的饱和或不饱和脂肪酸的酰基，X表示-CH2CH2-或-CH = CH-基团。 本发明涉及其中活性成分是所述化合物的药物产品，以及其中R2表示不饱和脂肪酸的酰基的那些化合物I及其制备方法。 （一）

    Iridium treatment of neuro-stimulating electrodes
    9.
    发明授权
    Iridium treatment of neuro-stimulating electrodes 失效

    公开(公告)号：US4721551A

    公开(公告)日：1988-01-26

    申请号：US927809

    申请日：1986-11-06

    申请人： Charles L. Byers ,  Peter Zimmerman ,  Paul Feinstein ,  Mitchell Sutter

    发明人： Charles L. Byers ,  Peter Zimmerman ,  Paul Feinstein ,  Mitchell Sutter

    IPC分类号： C25D7/00 ,  C25D3/50

    CPC分类号： C25D7/00

    摘要： Microelectrodes of the art are limited to the charge density which can pass through them. The present invention discloses a method for electroplating iridium metal onto the surface of a metallic microelectrode for use in a biomedical prosthetic device, which method comprises:(a) placing the metallic microelectrode into an aqueous solution of iridium ion of between about 1 and 10 percent by weight; and(b) electroplating the microelectrode of step (a) using a current of between about 0.5 and 15 milliamps wherein said current is controlled by a current controller. In another aspect the method discloses in step (b) the current is also biased and simultaneously applied in a mode wherein the current is equivalent to an impressed voltage of between about 1.5 and 6.0 volts positive.In other aspects, the method also includes the following :A-after step (b): (c) conditioning the microelectrode after step (b) by heating at a temperature of between about ambient and 350.degree. C.; B-after step (c): (c-1) optionally subjecting the iridium-coated microelectrode of step to ultrasonic energy in the range of between about 1 and 20,000 hertz for between about 0.1 and 10 minutes in a phosphate buffered saline solution; after step (c-1): (d) conditioning the microelectrode of step (c-1) by storage for between about 6 and 150 hrs. in a physiologically equivalent phosphate buffered saline solution selected under in vitro conditions; D-after step (c-1): (d-1) conditioning the microelectrode of step (b-1) by placing it in vivo and conducting the conditioning in the presence of minor amounts liquid selected from natural body fluids or added synthetic liquids; and E-after step (b): (e) conditioning the microelectrode between about positive 1 and negative 1 volts for between 100 and 10,000 millivolts per second, for between about 1 and 100 cycles to form at least one iridium oxide on the surface of the microelectrode. The invention also discloses the use of these microelectrodes in devices and in microelectrodes and in these devices used in the method of treatment of neurological diseases.